Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant in Incomplete Spinal Cord Injury
NCT05622994Phase 2Unknown
- Sponsor
- Hospital Nacional de Parapléjicos
- Start
- Nov 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rimonabant in spinal cord injury (SCI), sponsored by Hospital Nacional de Parapléjicos. Status: unknown.
02
Drugs
rimonabant
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT05622994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05622994.